Company Name:Innoviva Inc.
CEO: Eric d'Esparbes

Sector: Healthcare
Industry:Biotechnology

Exchange: Nasdaq Global Select

Country: USA

Description: Innoviva Inc is a biopharmaceutical company that is engaged in the discovery, development and commercialization of small molecule medicines. The firm collaborates with and receives funding from GlaxoSmithKline.


Key numbers

Market Capitalization:1237629380
Shares Outstanding: 101279000
Float: 68054727.887
Next Earning Date:2020-02-04
TTm EPS: 3.7129
TTm Dividend Rate:
200 days moving average:13.18
50 days moving average: 11.08
One day percent Change: 2.07



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,